NEW YORK, 23 November 2021 / PRNewswire / – Direxion (direxion.com) today announced the launch of the The Direxion Nanotechnology ETF (Witness: TYNE). TYNE invests in companies considered to be at the forefront of nanotechnology, spanning the traditional sectors of consumer discretionary, healthcare, industry, information technology and materials.

“Investors continue to seek exposure to disruptive industries, but one important area that they may not yet fully appreciate is nanotechnology,” said David Mazza, Managing Director, Product Manager at Direxion. “Nanotechnology is used today in a wide variety of businesses, ranging from agriculture to biotechnology, defense, energy and semiconductors. With this innovation, materials can be made stronger, lighter, more durable and more responsive, helping to reduce costs and increase productivity. “

The TYNE The ETF researches the investment results, before fees and expenses, of the S&P Kensho Extended Nanotechnology Index. The S&P Kensho Extended Nanotechnology Index tracks the performance of US listed companies involved in the creation and / or manipulation of matter at the molecular level (or smaller), providing one or more of the following four types of products or services : manufacturing and manufacturing processes, measurement and simulation, materials and delivery systems.

Investors seeking exposure to nanotechnology stocks and the nanotechnology sector can access US listed nanotechnology companies such as Moderna, Inc. (MRNA), Thermo Fisher Scientific (TMO), Nano Dimension Ltd. ADR (NNDM), BionTech SE (BNTX), Beam Therapeutics Inc. (BEAM) and others through this Nanotechnology ETF ($ TYNE). For other nanotechnology stocks, see the table below.

From November 12, 2021, the 29 components had a median total market capitalization of $ 4 billion, total market capitalizations ranging from $ 98 million To $ 250 billion, and were concentrated in the health and information technology sectors. The top ten stocks in the index are:

Source: Source: Bloomberg Finance, LP, S&P, at 31.10.2021.

About Direxion:

Direxion provides means for traders to execute short-term tactical trades and investors with strategic exposures and thematic strategies focused on emerging trends. Founded in 1997, the company has approximately $ 25.1 billion in assets under management at September 30, 2021. For more information, please visit www.direxion.com.

For more information on all Direxion Shares Daily Leveraged ETFs, visit direxion.com, or call us at 866.476.7523.

An investor should carefully consider the investment objective, risks, charges and expenses of a Fund before investing. The prospectus and the summary of the prospectus of a Fund contain this information as well as other information about the Direxion Shares. To obtain a Fund’s prospectus and prospectus summary, call 866-716-0735 or visit our website at direxion.com. The prospectus and the summary of the prospectus of a Fund should be read carefully before investing..

Risks associated with Direxion shares –
There are risks involved in investing, including the possible loss of major nanotechnology-related companies, may rely on a combination of patents, copyrights, trademarks and trade secret laws to establish and protect their property rights in their products and technologies and may be affected by the loss or alteration of these rights. Additionally, nanotechnology companies may have limited product lines, markets, financial resources, or personnel. Nanotechnology companies can be smaller, less experienced companies that can be more volatile than the overall market. Small and micro enterprises often have limited product lines, narrower markets for their goods and / or services, and more limited management and financial resources than larger, more established enterprises.

There is no guarantee that the investment strategy will be successful. Additional risks of the Fund include, but are not limited to, index correlation / tracking risk, index strategy risk, natural disaster / epidemic and market disruption risk, and associated risks. market capitalizations and sectors of securities in which the Fund may invest. Please see the summary and the full prospectus for a more complete description of these and other risks of the Fund.

Distributor: Foreside Fund Services, LLC.

CONTACT:
James doyle
JConnelly
973.850.7308
[email protected]

SOURCE Direction